Johnson & Johnson (JNJ) News

Johnson & Johnson (JNJ): $179.52

2.01 (+1.13%)

POWR Rating

Component Grades













Filter JNJ News Items

JNJ News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

JNJ News Highlights

  • For JNJ, its 30 day story count is now at 115.
  • Over the past 27 days, the trend for JNJ's stories per day has been choppy and unclear. It has oscillated between 1 and 28.
  • DRUG, PAY and DOW are the most mentioned tickers in articles about JNJ.

Latest JNJ News From Around the Web

Below are the latest news stories about Johnson & Johnson that investors may wish to consider to help them evaluate JNJ as an investment opportunity.

Johnson & Johnson given go-ahead for bankruptcy strategy on talc lawsuits

A bankruptcy court judge has upheld Johnson & Johnson's (JNJ +4.4%) request to use a bankruptcy strategy to handle 38K lawsuits related to its talc products pending against the company, The Wall Street Journal reports. The ruling by Judge Michael Kaplan of the U.S. Bankruptcy Court in Trenton, N.J., will...

Seeking Alpha | February 25, 2022

$26 billion opioid crisis settlement finalized with Johnson & Johnson, 3 drug distributors

Drug distributors McKesson, AmerisourceBergen and Cardinal Health are part of the settlement.

New York Daily News | February 25, 2022

Johnson & Johnson, Pharmaceutical Distributors Agree To $26 Billion Opioid Lawsuit Settlement

California is expected to receive $2.05 billion, while the City of Los Angeles could get "tens of millions" from the settlement.

CBS Los Angeles | February 25, 2022

Judge greenlights J&J strategy to resolve talc lawsuits in bankruptcy court By Reuters

© Reuters. The company logo for Johnson & Johnson is displayed to celebrate the 75th anniversary of the company’s listing at the New York Stock Exchange (NYSE) in New York, U.S., September 17, 2019. REUTERS/Brendan McDermid By Dietrich Knauth and Tom Hals (Reuters) -Johnson & Johnson can use the bankruptcy system to resolve multibillion-dollar litigation …

State Of Press | February 25, 2022

Dow Jones Surges As Putin Tightens Grip On Ukraine; Etsy Explodes; 3 Stocks Make Bullish Moves

The Dow Jones rallied as Vladimir Putin tightened his grip on Ukraine. Etsy stock soared on earnings, as did Block. Johnson & Johnson surged.

Investor''s Business Daily | February 25, 2022

Judge greenlights J&J strategy to resolve talc lawsuits in bankruptcy court

Johnson & Johnson can use the bankruptcy system to resolve multibillion-dollar litigation claiming its talc products cause cancer, a U.S. judge ruled on Friday, signing off on a legal maneuver that enables the company to avoid fighting more than 38,000 individual lawsuits.

Reuters | February 25, 2022

Johnson & Johnson Sees A Strong Move: Is It Ready For A Breakout?

Johnson & Johnson (NYSE: JNJ ) shares are trading higher Friday after the company agreed to finalize a proposed $26 billion settlement resolving more than 3,000 lawsuits, mainly by state and local governments, seeking to hold it and three other companies responsible for the opioid abuse crisis. The other companies are distributors McKesson Corp (NYSE: MCK ), AmerisourceBergen Corp (NYSE: ABC ) and Cardinal Health Inc (NYSE: CAH ). Johnson & Johnson was up 4.97% at $166 Friday afternoon at publication. See Also: Drug Distributors, JNJ Agree To Settle $26B Opioid Lawsuits Johnson & Johnson Daily Chart Analysis The stock recently bounced off support in a sideways channel and has been pushing higher, now nearing the resistance level of the channel. Support was found near … Full story availa...

Benzinga | February 25, 2022

3M rides Johnson & Johnson bankruptcy process ruling to 5% rally (NYSE:MMM)

3M(MMM) jumped nearly 5% in Friday''s trading, bouncing off its lowest levels in 21 months, perhaps helped by a court ruling that upheld Johnson Johnson''s request to use the…

Seeking Alpha | February 25, 2022

CDC eases COVID mask rules for most U.S. regions

Yahoo Finance's Anjalee Khemlani discusses the CDC's new guidelines for COVID-19 mask-wearing.

Yahoo | February 25, 2022

Emergent BioSolutions Stock Fell Today -- Is It a Buy?

Emergent BioSolutions (NYSE: EBS) ended the week on a down note. Shares of the company closed 6.2% lower on Friday after it provided its fourth-quarter update following the market close on Thursday. There certainly were some positive takeaways for investors in Emergent's Q4 results.

Yahoo | February 25, 2022

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.4713 seconds.